UConn studies human somatic cell genome editing
Human somatic cell genome editing is a promising treatment option for cardiovascular disorders, but concerns remain about the safety and efficacy of this therapeutic strategy....
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Human somatic cell genome editing is a promising treatment option for cardiovascular disorders, but concerns remain about the safety and efficacy of this therapeutic strategy....
Genesis Drug Discovery & Development, a member of Genesis Biotechnology Group, has acquired New England Discovery Partners (NEDP), a Contract Research Organization specializing in synthetic...
Achillion Pharmaceuticals reports that the FDA has reviewed and cleared the Investigational New Drug Application for ACH-5228, the company’s second-generation oral factor D inhibitor. The...
Azitra has appointed Jeanne M. Bertonis Chief Operating Officer. She joins Azitra from Visgo Therapeutics, Inc., a company focused on localized, sustained-release drug delivery, where she was Chief...
Thetis Pharmaceuticals has received funding from the Crohn’s & Colitis Foundation’s IBD Ventures program to support development of TP-317, a first-in-class, oral therapy for inflammatory bowel...
Intensity Therapeutics presented new data recently re its ongoing Phase 1/2 clinical study of INT230-6, the Company’s lead product candidate. INT230-6 is designed for direct...
Aeromics has announced a collaboration and exclusive license agreement with China’s Simcere Pharmaceutical Group for Aeromics’ AER-271, a clinical-stage anti-edema therapy, being developed for the...
Sema4 has announced announced the appointment of Joel Sendek as Chief Financial Officer. Mr. Sendek has more than 25 years of financial leadership experience in the...
The new owners of what once was the headquarters of financial services firm Higher One are looking to boost the occupancy rate of the 145,000-square...
State ‘desperately needs good regional airport in south central Connecticut,’ Gov. Ned Lamont says. Will it be Tweed New Haven or Sikorsky Memorial? … more...